FI55497C - Foerfarande foer framstaellning av terapeutiskt anvaendbara pge- och pgf-tetrazoylderivat - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara pge- och pgf-tetrazoylderivat

Info

Publication number
FI55497C
FI55497C FI2387/72A FI238772A FI55497C FI 55497 C FI55497 C FI 55497C FI 2387/72 A FI2387/72 A FI 2387/72A FI 238772 A FI238772 A FI 238772A FI 55497 C FI55497 C FI 55497C
Authority
FI
Finland
Prior art keywords
therapeutic
procedure
preparation
products
therapeutic products
Prior art date
Application number
FI2387/72A
Other languages
English (en)
Finnish (fi)
Other versions
FI55497B (fi
Inventor
Hans-Jurgen Ernst Hess
Thomas Ken Schaaf
Leonard Joseph Czuba
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of FI55497B publication Critical patent/FI55497B/fi
Publication of FI55497C publication Critical patent/FI55497C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI2387/72A 1971-09-01 1972-08-30 Foerfarande foer framstaellning av terapeutiskt anvaendbara pge- och pgf-tetrazoylderivat FI55497C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17710271A 1971-09-01 1971-09-01

Publications (2)

Publication Number Publication Date
FI55497B FI55497B (fi) 1979-04-30
FI55497C true FI55497C (fi) 1979-08-10

Family

ID=22647201

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2387/72A FI55497C (fi) 1971-09-01 1972-08-30 Foerfarande foer framstaellning av terapeutiskt anvaendbara pge- och pgf-tetrazoylderivat

Country Status (12)

Country Link
JP (1) JPS5724348B2 (xx)
AR (4) AR197304A1 (xx)
AT (3) AT327219B (xx)
CA (1) CA978939A (xx)
DK (1) DK144730C (xx)
ES (3) ES406250A1 (xx)
FI (1) FI55497C (xx)
FR (3) FR2283134A1 (xx)
IL (3) IL48544A (xx)
PH (3) PH10023A (xx)
SE (4) SE409032B (xx)
ZA (1) ZA725827B (xx)

Also Published As

Publication number Publication date
JPS5724348B2 (xx) 1982-05-24
DK144730C (da) 1982-10-18
FR2283134A1 (fr) 1976-03-26
ZA725827B (en) 1973-06-27
PH10416A (en) 1977-03-16
FR2283134B1 (xx) 1978-05-12
IL40183A0 (en) 1972-10-29
ES406250A1 (es) 1976-06-01
SE7606691L (sv) 1976-06-11
FR2283147B1 (xx) 1978-05-12
SE7606689L (sv) 1976-06-11
IL48544A0 (en) 1976-01-30
AT335079B (de) 1977-02-25
ES417558A1 (es) 1976-06-16
AR199574A1 (es) 1974-09-13
AR199784A1 (es) 1974-09-30
SE421525B (sv) 1982-01-04
AR199573A1 (es) 1974-09-13
PH10443A (en) 1977-03-25
FI55497B (fi) 1979-04-30
DK144730B (da) 1982-05-24
PH10023A (en) 1976-07-13
SE424185B (sv) 1982-07-05
JPS4834165A (xx) 1973-05-16
IL48544A (en) 1977-06-30
ATA743472A (de) 1976-06-15
IL40183A (en) 1977-06-30
SE7606690L (sv) 1976-06-11
ES417557A1 (es) 1976-06-16
SE409032B (sv) 1979-07-23
ATA51974A (de) 1975-04-15
AR197304A1 (es) 1974-03-29
FR2283147A1 (fr) 1976-03-26
FR2283136A1 (fr) 1976-03-26
AT327219B (de) 1976-01-26
FR2283136B1 (xx) 1978-05-12
CA978939A (en) 1975-12-02
SE421526B (sv) 1982-01-04

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE406197B (sv) Analogiforfarande for framstellning av 4-aminokinazolinderivat
SE411755B (sv) Forfarande for framstellning av n-substituerade 1-aminometylindaner
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE399069B (sv) Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat
SE417318B (sv) Forfarande for framstellning av oxofurylesterderivat av penicillin
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE398123B (sv) Forfarande for framstellning av metoximetylestern av hetacillin
SE409866B (sv) Forfarande for framstellning av adenosinderivat
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE404803B (sv) Analogiforfaranden for framstellning av pyrido-diazepiner
SE407061B (sv) Forfarande for framstellning av bensylpyrimidiner
SE387948B (sv) Forfarande for framstellning av tiofen
SE7806349L (sv) Mellanprodukter avsedda for framstellning av trien-steroidderivat
NO136975C (no) Fremgangsm}te til fremstilling av nitrilotriacetonitril